Shenzhen Capchem Technology (300037) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Q3 2024 revenue reached ¥2.08 billion, down 3.02% year-over-year; YTD revenue was ¥5.67 billion, up 1.51% year-over-year.
Net profit attributable to shareholders in Q3 was ¥285.67 million, up 1.89% year-over-year; YTD net profit was ¥701.47 million, down 12.00% year-over-year.
Operating cash flow for the first nine months was -¥189.84 million, a significant decline from ¥2.50 billion in the prior year period.
Financial highlights
Q3 basic EPS was ¥0.38, flat year-over-year; YTD basic EPS was ¥0.93, down 13.08% year-over-year.
Q3 gross margin and segment breakdowns not specified; YTD weighted average ROE was 7.48%, down 1.82 percentage points year-over-year.
Total assets at quarter-end were ¥17.14 billion, down 2.73% from year-end 2023; shareholders' equity rose 4.09% to ¥9.55 billion.
Non-recurring items reduced YTD net profit by ¥4.93 million; main items included government subsidies and investment gains.
Outlook and guidance
The company extended the expected operational date for a major lithium additive project to December 31, 2024.
Adjustments were made to the implementation and location of the Netherlands lithium battery electrolyte project.
Latest events from Shenzhen Capchem Technology
- Q1 2026 saw revenue up 67.85% and net profit up 109.02% year-over-year.300037
Q1 202628 Apr 2026 - Revenue up 4.85%, net profit down 6.83%, strong global expansion and R&D investment.300037
Q4 202426 Dec 2025 - Q3 2025 revenue up 13.6%, net profit down 7.5%, with strong cash flow and higher R&D spend.300037
Q3 202529 Oct 2025 - H1 2025 revenue up 18.58%, net profit up 16.36%, with strong growth across all segments.300037
Q2 202526 Aug 2025 - Revenue up 4.35% but net profit down 19.54% as margin pressure persists; global expansion continues.300037
Q2 202413 Jun 2025 - Q1 2025 net profit surged 39% year-over-year on strong revenue growth and improved margins.300037
Q1 20256 Jun 2025